Wednesday, August 06, 2025 11:01:55 AM
If by downplay you mean I pointed out the information was 7 years old, then you are correct. I was mistaken, "This was the DCVax method fully implemented, 8 years ago, in pediatric sarcomas."
All information concerning NWBO is critical. From manufacturing to compassionate care to TLD.
The study results are amazing.
What I am downplaying is this new, unproven notion that NWBO has allready applied to the FDA in secret.
Andrew has provided fantastic analysis of NWBO's methods, products and systems. However, saying, in his opinion, NWBO has applied to FDA and a 2 month approval is on the table due to the CVPV is unproven.
Is it possible? anything's possible, but pushing that theory, in the manner he has, means he has insider information or is just making another guess. Some people are lapping it up like it was a bottle of water on a 100 degree day. There is no proof.
I can make a case that Merck allready has a deal with NWBO by piecing together information. It would be possible, but there is no proof that such a deal exists so one can either believe it or not. Just about every prediction about this company put forth here has been wrong. Now someone says we applied to FDA in secret and approval can be in 2 months. Just because we wish it doesn't make it so. So if I'm downplaying anything or sounding like FUD, so be it. I've believed far too many predictions that have not come true so forgive me for being skeptical and downplaying anything until I see it from the company.
All information concerning NWBO is critical. From manufacturing to compassionate care to TLD.
The study results are amazing.
What I am downplaying is this new, unproven notion that NWBO has allready applied to the FDA in secret.
Andrew has provided fantastic analysis of NWBO's methods, products and systems. However, saying, in his opinion, NWBO has applied to FDA and a 2 month approval is on the table due to the CVPV is unproven.
Is it possible? anything's possible, but pushing that theory, in the manner he has, means he has insider information or is just making another guess. Some people are lapping it up like it was a bottle of water on a 100 degree day. There is no proof.
I can make a case that Merck allready has a deal with NWBO by piecing together information. It would be possible, but there is no proof that such a deal exists so one can either believe it or not. Just about every prediction about this company put forth here has been wrong. Now someone says we applied to FDA in secret and approval can be in 2 months. Just because we wish it doesn't make it so. So if I'm downplaying anything or sounding like FUD, so be it. I've believed far too many predictions that have not come true so forgive me for being skeptical and downplaying anything until I see it from the company.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
